Mark Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Mark Therapeutics General Information
Description
Developer of novel antimicrobial therapies designed to treat multidrug-resistant pathogens. The company is currently operating in Stealth mode.
Contact Information
Corporate Office
- Number 12-10-587/2/B
- Road Number 4, Medibhavi, Seethafalmandi
- Secunderabad, Telangana 500061
- India
Corporate Office
- Number 12-10-587/2/B
- Road Number 4, Medibhavi, Seethafalmandi
- Secunderabad, Telangana 500061
- India
Mark Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Mar-2021 | Completed | Stealth |
Mark Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mark Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ASPIRE-BioNEST | Accelerator/Incubator |
Mark Therapeutics FAQs
-
When was Mark Therapeutics founded?
Mark Therapeutics was founded in 2019.
-
Where is Mark Therapeutics headquartered?
Mark Therapeutics is headquartered in Secunderabad, India.
-
What industry is Mark Therapeutics in?
Mark Therapeutics’s primary industry is Biotechnology.
-
Is Mark Therapeutics a private or public company?
Mark Therapeutics is a Private company.
-
What is Mark Therapeutics’s current revenue?
The current revenue for Mark Therapeutics is .
-
Who are Mark Therapeutics’s investors?
ASPIRE-BioNEST has invested in Mark Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
